However, the number of children who completed all the three doses was less in the SP plus AQ treatment group (77%) compared to the SP plus PQ (87.5%) and DHA plus PQ (86%) groups (chi-square = 16.4, df = 2, p-value<0.001).
The trend was similar in younger versus older men but the gain of fat mass at the lowest testosterone dose was less prominent in older patients (Bhasin et al 2001; Bhasin et al 2005).
The percentage of subjects reporting at least one unsolicited symptom within the 31 day follow up period after the administration of any vaccination dose was less than 6% in any of the groups.
Prior adjuvant CMF was allowed if stopped at least 6 months before study entry; prior adjuvant anthracyclines were permitted if the total cumulative dose was less than 280 mg m−2 in case of doxorubicin and 360 mg m−2 in case of epirubicin and if stopped at least 12 months before study entry; prior adjuvant taxanes were not allowed.
This dose level, as well as the age and gender composition of our participants, is similar to previous reports from Japan [ 9, 25], but the dose is less than that reported in similar studies in the United States and Europe [ 8].
When INH was administered in food, it produced INH blood levels in mice that were comparable to therapeutic levels in humans, but the blood levels in rats at the same dose were less than half those in mice.
And seeds that have had a chemical dose are less likely to rot in the ground, which is an issue in cold, damp climates.
Although slightly higher than the average recommended therapeutic dosages in humans, this dose is less than twofold the highest recommended dose in clinical practice.
Increases in the 50th (120%, P <.05) and 90th (31%) percentiles and all percentiles of tPo2 after the second and third HBOC-201 dose were less pronounced but higher than in the RBC group.
Start and stop dates and changes in dose were always recorded and identifiable in comparison with handwritten prescriptions where changes in doses were less likely to be dated and signed by the prescriber.
